Performance de glicosímetro utilizado no automonitoramento glicêmico de portadores de diabetes mellitus tipo 1
Mira, Giane Sprada; Candido, Lys Mary Bileski; Yale, Jean François.
Arq. bras. endocrinol. metab
; 50(3): 541-549, jun. 2006. tab
Artículo en Portugués | LILACS | ID: lil-433749
Documentos relacionados
Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal.
TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.
MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection.
The impact of stigma on the management of type 1 diabetes: A systematic review.
Advances in Immunotherapeutic Approaches to Type 1 Diabetes.
Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and Psychosocial Interdisciplinary Considerations and Key Recommendations.
Th2 cell clonal expansion at diagnosis in human type 1 diabetes.
A reply to "TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes".
Necrobiosis Lipoidica.
Effects of an educational program on self-efficacy towards type 1 diabetes mellitus disease among parents and adolescents in Jordan.